Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP221951.RAPFRbQYuZZe9lRluHkipbsyRLLSJjMMo5FvtDLNa1AOs130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221951.RAPFRbQYuZZe9lRluHkipbsyRLLSJjMMo5FvtDLNa1AOs130_provenance.
• NP874189.RAhY94Y850s83qHve9wLRyb5MqzJAb1shXgmael2lCbjU130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874189.RAhY94Y850s83qHve9wLRyb5MqzJAb1shXgmael2lCbjU130_provenance.
• NP699702.RAal96aj3yJyukPXKXHuvQbylcXfnRA6xRINCpE3drhKo130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699702.RAal96aj3yJyukPXKXHuvQbylcXfnRA6xRINCpE3drhKo130_provenance.
• NP783394.RAO9hmlrBrQ4lBKyYnVaXWIWVXomYhR0WrltM3om80Ebg130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783394.RAO9hmlrBrQ4lBKyYnVaXWIWVXomYhR0WrltM3om80Ebg130_provenance.
• assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842518.RAGSXQX1iEKjHe4pXz9CY8wY7QRFKaTrXnrtx8vYc4Kqk130_provenance.
• NP981664.RAmKqFJSHcupDCdG9cEzYV6nN_CLRw5JFa0FKMcnNxSWw130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981664.RAmKqFJSHcupDCdG9cEzYV6nN_CLRw5JFa0FKMcnNxSWw130_provenance.
• NP572000.RAnHn91D0jpEA0Ti98NpFBWSMY2nnNf14ooGgdRr4o1Vc130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572000.RAnHn91D0jpEA0Ti98NpFBWSMY2nnNf14ooGgdRr4o1Vc130_provenance.
• NP981651.RAGs2fwCbxOYww-DDnpt8viiqtKg8ZHZRgQPe_DlL0pdk130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981651.RAGs2fwCbxOYww-DDnpt8viiqtKg8ZHZRgQPe_DlL0pdk130_provenance.
• NP981654.RAFR3FWNGU_PkwuizUNSKfDbwnlQVKSgDGbSxqXsoRaRo130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981654.RAFR3FWNGU_PkwuizUNSKfDbwnlQVKSgDGbSxqXsoRaRo130_provenance.
• NP571999.RAx4Q1AZ3OmLS4y6pUePKEm-AE8KDlRRFBxERGvpdGMm4130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571999.RAx4Q1AZ3OmLS4y6pUePKEm-AE8KDlRRFBxERGvpdGMm4130_provenance.
• NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_assertion description "[Anti-GOR was detected in serum from 59 (81%) of 73 patients with chronic NANBH, 40 (65%) of 62 with NANB liver cirrhosis, and 25 (63%) of 40 NANB patients with primary hepatocellular carcinoma, but in only less than 10% of patients with chronic liver diseases due to hepatitis B virus, alcohol, or an autoimmune disorder, and in only 2% of voluntary blood donors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572002.RA0u8Md0teHXirKmYwzELQLG8W2lCptVZVrBWASYZIv5I130_provenance.